We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+23.6%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$4.96B
AUM Growth
+$1.52B
Cap. Flow
+$955M
Cap. Flow %
19.25%
Top 10 Hldgs %
29.19%
Holding
2,861
New
1,030
Increased
290
Reduced
379
Closed
1,085

Sector Composition

Rank Sector Weight
1 Technology 17.2%
2 Consumer Discretionary 10.95%
3 Financials 6.92%
4 Communication Services 6.55%
5 Healthcare 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLOP
1626
DELISTED
GASLOG PARTNERS LP
GLOP
$109K ﹤0.01%
40,296
-37,366
-48% -$114K
LOACW
1627
DELISTED
Longevity Acquisition Corporation Warrant
LOACW
$107K ﹤0.01%
68,758
LSEAW
1628
DELISTED
Landsea Homes Corporation Warrant
LSEAW
$105K ﹤0.01%
54,246
AQST icon
1629
Aquestive Therapeutics
AQST
$494M
$104K ﹤0.01%
+19,521
New +$117K
GCMGW
1630
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
$104K ﹤0.01%
+59,501
New +$84.9K
NVVEW
1631
DELISTED
Newborn Acquisition Corp Warrant
NVVEW
$103K ﹤0.01%
31,993
+1,636
+5% +$2.21K
TACO
1632
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$101K ﹤0.01%
+11,176
New +$96.8K
PSO icon
1633
Pearson
PSO
$9.9B
$100K ﹤0.01%
+11,000
New +$88.1K
ABUS icon
1634
Arbutus Biopharma
ABUS
$915M
$99K ﹤0.01%
+28,054
New +$98.2K
SKLZ.WS
1635
DELISTED
Skillz Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exe
SKLZ.WS
$98K ﹤0.01%
+13,680
New +$99.8K
CELUW
1636
DELISTED
Celularity Inc
CELUW
$97K ﹤0.01%
33,823
-100
-0.3% -$187
GRTS
1637
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$97K ﹤0.01%
+24,685
New +$74.7K
GSKY
1638
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$97K ﹤0.01%
+21,109
New +$95.5K
PAYAW
1639
DELISTED
Paya Holdings Inc. Warrant
PAYAW
$97K ﹤0.01%
+26,945
New +$74K
CLNNW
1640
DELISTED
Clene Inc Warrant
CLNNW
$95K ﹤0.01%
+92,180
New +$92.2K
CRON
1641
Cronos Group
CRON
$1.14B
$95K ﹤0.01%
+13,786
New +$94.9K
HIO
1642
Western Asset High Income Opportunity Fund
HIO
$340M
$95K ﹤0.01%
19,194
+2,037
+12% +$10.2K
VKTX icon
1643
Viking Therapeutics
VKTX
$4B
$94K ﹤0.01%
+16,801
New +$102K
SJ icon
1644
Scienjoy Holding
SJ
$38.3M
$93K ﹤0.01%
10,782
-4,530
-30% -$35.5K
IHIT
1645
DELISTED
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
$92K ﹤0.01%
+11,000
New +$89.8K
CRK icon
1646
Comstock Resources
CRK
$3.94B
$91K ﹤0.01%
+20,990
New +$104K
MRC
1647
DELISTED
MRC Global
MRC
$90K ﹤0.01%
13,584
-116,326
-90% -$642K
RVPHW
1648
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
$89K ﹤0.01%
132,624
CNR
1649
Core Natural Resources Inc
CNR
$4.45B
$89K ﹤0.01%
+12,473
New +$65.3K
HL icon
1650
Hecla Mining
HL
$11.3B
$88K ﹤0.01%
13,603
-6,518
-32% -$34.7K

Similar funds

HRT Financial's Q4 2020 Portfolio in Review

As of Q4 2020, HRT Financial held 2,861 positions worth $4.96B, up 44% from $3.44B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

HRT Financial deployed $955M of net new capital in Q4 2020, opening 1,030 new positions and adding to 290 existing holdings. Its largest new stake was Microsoft: 872,030 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 3000 ETF, an estimated $60.6M trimmed.

  • HRT Financial's largest Q4 2020 buy was Microsoft: 872,030 shares worth $194M.
  • HRT Financial added most to Amazon in Q4 2020, an estimated $185M increase.
  • HRT Financial's biggest Q4 2020 reduction was iShares Russell 3000 ETF, cutting an estimated $60.6M.
  • HRT Financial fully exited Tesla in Q4 2020, selling an estimated $97.4M.
  • HRT Financial's ten largest holdings make up 29% of its $4.96B portfolio in Q4 2020.
  • HRT Financial opened 1,030 new positions and closed 1,085 in Q4 2020.
  • HRT Financial's portfolio value rose 44% quarter-over-quarter to $4.96B.

Based on HRT Financial's 13F filing for Q4 2020, filed 16 Feb 2021.